Ceramide-Protein Interactions Modulate Ceramide-Associated Lipotoxic Cardiomyopathy.
Ontology highlight
ABSTRACT: Lipotoxic cardiomyopathy (LCM) is characterized by abnormal myocardial accumulation of lipids, including ceramide; however, the contribution of ceramide to the etiology of LCM is unclear. Here, we investigated the association of ceramide metabolism and ceramide-interacting proteins (CIPs) in LCM in the Drosophila heart model. We find that ceramide feeding or ceramide-elevating genetic manipulations are strongly associated with cardiac dilation and defects in contractility. High ceramide-associated LCM is prevented by inhibiting ceramide synthesis, establishing a robust model of direct ceramide-associated LCM, corroborating previous indirect evidence in mammals. We identified several CIPs from mouse heart and Drosophila extracts, including caspase activator Annexin-X, myosin chaperone Unc-4
SUBMITTER: Walls SM
PROVIDER: S-EPMC6242704 | biostudies-literature | 2018 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA